No abstract available
MeSH terms
-
Antiviral Agents / adverse effects
-
Antiviral Agents / therapeutic use*
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
Clinical Trials as Topic* / methods
-
Clinical Trials as Topic* / standards
-
Compassionate Use Trials
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / therapy*
-
Coronavirus Infections / transmission
-
Critical Care / methods
-
Humans
-
International Cooperation*
-
Pandemics
-
Patient Care / methods*
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / therapy*
-
Pneumonia, Viral / transmission
-
Research Design
-
Respiration, Artificial
-
SARS-CoV-2
-
Treatment Outcome
-
World Health Organization